Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 159 articles: HTML format

Single Articles

April 2020
1. TOYA T, Corban MT, Imamura K, Bois JP, et al
   Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction.
   Atherosclerosis. 2020;302:27-35.
   PubMed     Abstract available
   
   
   
2. PAN W, Sun M, Wu J, Dong H, et al
   Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction.
   Atherosclerosis. 2020;302:8-14.
   PubMed     Abstract available
   
   
   
3. KIM YH, Her AY, Jeong MH, Kim BK, et al
   Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation
   Atherosclerosis. 2020;301:54-64.
   PubMed     Abstract available
   
   
   
4. TIAN X, Zuo Y, Chen S, Li H, et al
   Association of changes in lipids with risk of myocardial infarction among people without lipid-lowering therapy.
   Atherosclerosis. 2020;301:69-78.
   PubMed     Abstract available
   
   
   March 2020
5. LI B, Luo YR, Tian F, Chen YD, et al
   Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes.
   Atherosclerosis. 2020;300:10-18.
   PubMed     Abstract available
   
   
   
6. OLSON NC, Sitlani CM, Doyle MF, Huber SA, et al
   Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts.
   Atherosclerosis. 2020 Mar 16. pii: S0021-9150(20)30147.
   PubMed     Abstract available
   
   
   
7. LI CK, Xu Z, Ho J, Lakhani I, et al
   Association of NPAC score with survival after acute myocardial infarction.
   Atherosclerosis. 2020;301:30-36.
   PubMed     Abstract available
   
   
   
8. CURE E, Cumhur Cure M
   Comment on: "High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment".
   Atherosclerosis. 2020;296:2-3.
   PubMed    
   
   
   February 2020
9. SANTOS RD
   Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality: Can the power of zero be expanded beyond the vessels?
   Atherosclerosis. 2020;294:44-45.
   PubMed    
   
   
   January 2020
10. PU X, Chan K, Yang W, Xiao Q, et al
    Effect of a coronary-heart-disease-associated variant of ADAMTS7 on endothelial cell angiogenesis.
    Atherosclerosis. 2020;296:11-17.
    PubMed     Abstract available
    
    
    December 2019
11. REYES C, Pons NA, Renones CR, Gallisa JB, et al
    Association between serum ferritin and acute coronary heart disease: A population-based cohort study.
    Atherosclerosis. 2019;293:69-74.
    PubMed     Abstract available
    
    
    
12. OHUKAINEN P, Kuusisto S, Kettunen J, Perola M, et al
    Data-driven multivariate population subgrouping via lipoprotein phenotypes versus apolipoprotein B in the risk assessment of coronary heart disease.
    Atherosclerosis. 2019;294:10-15.
    PubMed     Abstract available
    
    
    November 2019
13. LI W, Shu S, Cheng L, Hao X, et al
    Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions.
    Atherosclerosis. 2019;292:193-200.
    PubMed     Abstract available
    
    
    August 2019
14. ISIOZOR NM, Kunutsor SK, Voutilainen A, Kurl S, et al
    Ideal cardiovascular health and risk of acute myocardial infarction among Finnish men.
    Atherosclerosis. 2019;289:126-131.
    PubMed     Abstract available
    
    
    
15. FANG C, Dai J, Zhang S, Wang Y, et al
    Culprit lesion morphology in young patients with ST-segment elevated myocardial infarction: A clinical, angiographic and optical coherence tomography study.
    Atherosclerosis. 2019;289:94-100.
    PubMed     Abstract available
    
    
    
16. RAMPIDIS GP, Benetos G, Benz DC, Giannopoulos AA, et al
    A guide for Gensini Score calculation.
    Atherosclerosis. 2019;287:181-183.
    PubMed    
    
    
    July 2019
17. VELLE-FORBORD T, Eidlaug M, Debik J, Saether JC, et al
    Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study.
    Atherosclerosis. 2019;289:1-7.
    PubMed     Abstract available
    
    
    May 2019
18. KOWALL B, Stang A
    Reply to: "Methodological issues regarding "Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study"".
    Atherosclerosis. 2019 May 4. pii: S0021-9150(19)30401.
    PubMed    
    
    
    
19. IACOBELLIS G, Mahabadi AA
    Is epicardial fat attenuation a novel marker of coronary inflammation?
    Atherosclerosis. 2019;284:212-213.
    PubMed    
    
    
    April 2019
20. DE BACKER G, Jankowski P, Kotseva K, Mirrakhimov E, et al
    Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
    Atherosclerosis. 2019;285:135-146.
    PubMed     Abstract available
    
    
    
21. BIDHENDI YARANDI R, Panahi MH
    Methodological issues regarding "Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study".
    Atherosclerosis. 2019 Apr 17. pii: S0021-9150(19)30382.
    PubMed    
    
    
    March 2019
22. RUGE T, Carlsson AC, Kjoller E, Hilden J, et al
    Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study.
    Atherosclerosis. 2019;284:202-208.
    PubMed     Abstract available
    
    
    January 2019
23. PLANAS-BALLVE A, Crespo AM, Aguilar LM, Hernandez-Perez M, et al
    The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events.
    Atherosclerosis. 2019;282:132-136.
    PubMed     Abstract available
    
    
    
24. LIU X, Li J, Liao J, Wang H, et al
    Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr(-/-) mice.
    Atherosclerosis. 2019;282:100-109.
    PubMed     Abstract available
    
    
    
25. WADA H, Dohi T, Miyauchi K, Daida H, et al
    Reply to: "Comment on "Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease" ".
    Atherosclerosis. 2019;280:195-196.
    PubMed    
    
    
    
26. COBAN E
    Comment on "Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease".
    Atherosclerosis. 2019;280:194.
    PubMed    
    
    
    December 2018
27. SANTOS RD, Watts GF
    Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH.
    Atherosclerosis. 2018 Dec 22. pii: S0021-9150(18)31544.
    PubMed    
    
    
    
28. ZHAO Y, Evans MA, Allison MA, Bertoni AG, et al
    Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2018 Dec 15. pii: S0021-9150(18)31525.
    PubMed     Abstract available
    
    
    
29. SOARES AAS, Carvalho LSF, Bonilha I, Virginio VW, et al
    Adverse interaction between HDL and the mass of myocardial infarction.
    Atherosclerosis. 2018;281:9-16.
    PubMed     Abstract available
    
    
    November 2018
30. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
    Atherosclerosis. 2018;280:166-173.
    PubMed     Abstract available
    
    
    
31. VAHAMURTO L, Pahkala K, Magnussen CG, Hutri-Kahonen N, et al
    Coronary heart disease risk factor levels in eastern and western Finland from 1980 to 2011 in the cardiovascular risk in Young Finns study.
    Atherosclerosis. 2018;280:92-98.
    PubMed     Abstract available
    
    
    
32. HUMPHRIES SE, Cooper JA, Capps N, Durrington PN, et al
    Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register.
    Atherosclerosis. 2018 Nov 12. pii: S0021-9150(18)31469.
    PubMed     Abstract available
    
    
    October 2018
33. YANG R, Song Z, Wu S, Wei Z, et al
    Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
    Atherosclerosis. 2018;279:23-31.
    PubMed     Abstract available
    
    
    
34. KANURI SH, Ipe J, Kassab K, Gao H, et al
    Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
    Atherosclerosis. 2018;278:232-239.
    PubMed     Abstract available
    
    
    
35. AFANASIEVA OI, Ezhov MV, Razova OA, Afanasieva MI, et al
    Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
    Atherosclerosis. 2018;277:477-482.
    PubMed     Abstract available
    
    
    
36. PANG J, David Marais A, Blom DJ, Brice BC, et al
    Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
    Atherosclerosis. 2018;277:470-476.
    PubMed     Abstract available
    
    
    
37. ALNOURI F, Athar M, Al-Allaf FA, Abduljaleel Z, et al
    Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Atherosclerosis. 2018;277:425-433.
    PubMed     Abstract available
    
    
    
38. HARADA-SHIBA M, Ako J, Arai H, Hirayama A, et al
    Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
    Atherosclerosis. 2018;277:362-368.
    PubMed     Abstract available
    
    
    September 2018
39. WUOPIO J, Hilden J, Bring C, Kastrup J, et al
    Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
    Atherosclerosis. 2018;278:97-102.
    PubMed     Abstract available
    
    
    
40. SOLBU MD, Kolset SO, Jenssen TG, Wilsgaard T, et al
    Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromso Study.
    Atherosclerosis. 2018;278:166-173.
    PubMed     Abstract available
    
    
    
41. ALKHALIL M, Biasiolli L, Akbar N, Galassi F, et al
    T2 mapping MRI technique quantifies carotid plaque lipid, and its depletion after statin initiation, following acute myocardial infarction.
    Atherosclerosis. 2018 Sep 6. pii: S0021-9150(18)31343.
    PubMed     Abstract available
    
    
    
42. BEYAN C, Beyan E
    Mean platelet volume may not have a role in the prediction of adverse events after percutaneous coronary intervention in patients with ST elevation myocardial infarction.
    Atherosclerosis. 2018;276:204-205.
    PubMed    
    
    
    
43. WANG Y, Zhu J, Handberg A, Overvad K, et al
    Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and women.
    Atherosclerosis. 2018;277:163-168.
    PubMed     Abstract available
    
    
    August 2018
44. BYUN JK, Choi BG, Rha SW, Choi SY, et al
    Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
    Atherosclerosis. 2018;277:130-135.
    PubMed     Abstract available
    
    
    July 2018
45. MACHADO GP, de Araujo GN, Wainstein M
    Reply to "Mean platelet volume may not have a role in the prediction of adverse events after percutaneous coronary intervention in patients with ST-elevation myocardial infarction".
    Atherosclerosis. 2018 Jul 21. pii: S0021-9150(18)31217.
    PubMed    
    
    
    June 2018
46. SCHRODER J, Zethner-Moller R, Bove KB, Mygind ND, et al
    Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease.
    Atherosclerosis. 2018;275:319-327.
    PubMed     Abstract available
    
    
    May 2018
47. BALCER B, Dykun I, Schlosser T, Forsting M, et al
    Pericoronary fat volume but not attenuation differentiates culprit lesions in patients with myocardial infarction.
    Atherosclerosis. 2018 May 25. pii: S0021-9150(18)30278.
    PubMed     Abstract available
    
    
    
48. VENEGAS-PINO DE, Lagrotteria A, Wang PW, Morphet J, et al
    Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE(-/-):Ins2(+/Akita) mouse fed a western diet.
    Atherosclerosis. 2018;275:88-96.
    PubMed     Abstract available
    
    
    
49. MACHADO GP, Araujo GN, Carpes CK, Lech M, et al
    Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Atherosclerosis. 2018;274:212-217.
    PubMed     Abstract available
    
    
    
50. DONG SY, Yan ST, Wang ML, Li ZB, et al
    Associations of body weight and weight change with cardiovascular events and mortality in patients with coronary heart disease.
    Atherosclerosis. 2018;274:104-111.
    PubMed     Abstract available
    
    
    
51. SHEN ZX, Yang QZ, Li C, Du LJ, et al
    Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
    Atherosclerosis. 2018;274:199-205.
    PubMed     Abstract available
    
    
    
52. RAGGI P
    Angina severity, therapeutic choices and outcome in patients with diabetes mellitus.
    Atherosclerosis. 2018 May 3. pii: S0021-9150(18)30223.
    PubMed    
    
    
    
53. HUMPHRIES SE, Cooper JA, Seed M, Capps N, et al
    Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
    Atherosclerosis. 2018;274:41-46.
    PubMed     Abstract available
    
    
    April 2018
54. WILCOX T, Newman JD, Maldonado TS, Rockman C, et al
    Peripheral vascular disease risk in diabetic individuals without coronary heart disease.
    Atherosclerosis. 2018 Apr 30. pii: S0021-9150(18)30211.
    PubMed     Abstract available
    
    
    
55. LAVIN B, Protti A, Lorrio S, Dong X, et al
    MRI with gadofosveset: A potential marker for permeability in myocardial infarction.
    Atherosclerosis. 2018 Apr 25. pii: S0021-9150(18)30209.
    PubMed     Abstract available
    
    
    March 2018
56. DHAR I, Lysne V, Seifert R, Svingen GFT, et al
    Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors.
    Atherosclerosis. 2018;272:175-181.
    PubMed     Abstract available
    
    
    
57. WILLIAMS BA, Chagin KM, Bash LD, Boden WE, et al
    External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
    Atherosclerosis. 2018;272:80-86.
    PubMed     Abstract available
    
    
    
58. CARLSSON AC, Jansson JH, Soderberg S, Ruge T, et al
    Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Atherosclerosis. 2018;272:41-46.
    PubMed     Abstract available
    
    
    February 2018
59. RAGGI P
    Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: Computed tomography and positron emission tomography applications.
    Atherosclerosis. 2018;271:77-83.
    PubMed     Abstract available
    
    
    
60. YIN H, Pickering JG
    Aortic smooth muscle cells and myocardial infarction: Does the ascending aorta feel a heart attack?
    Atherosclerosis. 2018 Feb 10. pii: S0021-9150(18)30080.
    PubMed    
    
    
    January 2018
61. PELCZARSKA A, Jakubczyk M, Jakubiak-Lasocka J, Banach M, et al
    The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Atherosclerosis. 2018;270:132-138.
    PubMed     Abstract available
    
    
    
62. MARACLE CX, Agca R, Helder B, Meeuwsen JAL, et al
    Noncanonical NF-kappaB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
    Atherosclerosis. 2018;270:33-41.
    PubMed     Abstract available
    
    
    
63. WONGSURAWAT T, Woo CC, Giannakakis A, Lin XY, et al
    Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction.
    Atherosclerosis. 2018 Jan 29. pii: S0021-9150(18)30024.
    PubMed     Abstract available
    
    
    
64. MULE G, Vadala M, Geraci G, Cottone S, et al
    Retinal vascular imaging in cardiovascular medicine: New tools for an old examination.
    Atherosclerosis. 2018;268:188-190.
    PubMed    
    
    
    December 2017
65. HAMAZAKI K, Iso H, Eshak ES, Ikehara S, et al
    Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
    Atherosclerosis. 2017 Dec 8. pii: S0021-9150(17)31423.
    PubMed     Abstract available
    
    
    
66. NISHIHIRA K, Shibata Y, Yamashita A, Kuriyama N, et al
    Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction.
    Atherosclerosis. 2017;268:138-144.
    PubMed     Abstract available
    
    
    October 2017
67. ERCAN E
    Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality.
    Atherosclerosis. 2017 Oct 23. pii: S0021-9150(17)31348.
    PubMed     Abstract available
    
    
    September 2017
68. CHUNG CM, Lin MS, Chang CH, Cheng HW, et al
    Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
    Atherosclerosis. 2017 Sep 27. pii: S0021-9150(17)31288.
    PubMed     Abstract available
    
    
    
69. POKHAREL Y, Sharma PP, Qintar M, Lu Y, et al
    High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
    Atherosclerosis. 2017;266:16-23.
    PubMed     Abstract available
    
    
    
70. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study.
    Atherosclerosis. 2017;265:147-154.
    PubMed     Abstract available
    
    
    August 2017
71. GITT AK, Lautsch D, Ferrieres J, De Ferrari GM, et al
    Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Atherosclerosis. 2017;266:158-166.
    PubMed     Abstract available
    
    
    
72. ATTARD R, Dingli P, Doggen CJM, Cassar K, et al
    The independent effect of helicobacter pylori infection and elevated gastrin levels on the risk of myocardial infarction.
    Atherosclerosis. 2017;263:e96-e97.
    PubMed    
    
    
    
73. WOO CC, Wongsurawat T, Soong R, Lee CN, et al
    Distinctive pattern of LET-7B and MIR-30B in human aortic smooth muscle cells of myocardial infarction patients.
    Atherosclerosis. 2017;263:e63.
    PubMed    
    
    
    
74. KIM TH, Kang K, Kim EM, Park HE, et al
    Mesenchymal stem cells promote the infiltration of myeloid derived suppressor cells in a mouse myocardial infarction model.
    Atherosclerosis. 2017;263:e60.
    PubMed    
    
    
    
75. KURDI A, De Meyer GRY, Martinet W
    Everolimus attenuates atherosclerotic plaque progression, intraplaque neovascularization, myocardial infarction and sudden death in a mouse model of advanced atherosclerosis.
    Atherosclerosis. 2017;263:e59.
    PubMed    
    
    
    
76. DOULAMIS I, Tzani A, Konstantopoulos P, Gkogkos A, et al
    Sirtuin-1 and MMP-2 levels in patients with advanced coronary artery disease: A combined index for incidence of myocardial infarction.
    Atherosclerosis. 2017;263:e53.
    PubMed    
    
    
    
77. RYAZANKINA N, Manchurov V, Vasilieva E, Shpektor A, et al
    Improved in-hospital clinical outcomes in patients with acute ST-elevation myocardial infarction undergoing remote ischemic preconditioning before primary percutaneous coronary intervention.
    Atherosclerosis. 2017;263:e49-e50.
    PubMed    
    
    
    
78. MARINKOVIC G, Winkler L, Kefene L, Nilsson J, et al
    The alarmin complex S100A8/9 as a potential therapeutic target after myocardial infarction.
    Atherosclerosis. 2017;263:e48-e49.
    PubMed    
    
    
    
79. PFETSCH V, Sanin V, Jaensch A, Dallmeier D, et al
    Increased concentrations of soluble ST2 independently predict cardiac and total mortality but not non-fatal cardiovascular events in stable coronary heart disease patients.
    Atherosclerosis. 2017;263:e46-e47.
    PubMed    
    
    
    
80. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
    Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IGG-related coronary heart disease prediction in the general population.
    Atherosclerosis. 2017;263:e45.
    PubMed    
    
    
    
81. PECHERINA T, Kashtalap V, Barbarash O
    Effects of statins on inflammatory markers and matrix metalloproteinases in patients with ST-segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e45-e46.
    PubMed    
    
    
    
82. BOUZID K, Ben Ahmed H, Boussaid H, Kamoun M, et al
    Relationship between galectin-3 levels in ST elevation myocardial infarction and the burden of atherosclerosis.
    Atherosclerosis. 2017;263:e275.
    PubMed    
    
    
    
83. NIZOMOV A, Kenjaev S
    Effect of high-dose atorvastatin on lipid spectrum and inflammation in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245-e246.
    PubMed    
    
    
    
84. AZIZ N, Sirojiddin K, Majid K
    Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245.
    PubMed    
    
    
    
85. GRAESDAL A, Dybvig A
    Lipoprotein apheresis as a treatment modality for familial combined hyperlipidemia (FCH) with non-alcoholic fatty liver disease (NAFLD) and coronary heart disease: a casuistic approach.
    Atherosclerosis. 2017;263:e243-e244.
    PubMed    
    
    
    
86. BATURINA O, Mironova O
    Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
    Atherosclerosis. 2017;263:e227-e228.
    PubMed    
    
    
    
87. REVNIC CR, Revnic F, Pena C, Nica AS, et al
    Biochemical studies of atherogenic potential of serum from patients with unstable angina coronary atherosclerosis.
    Atherosclerosis. 2017;263:e219-e220.
    PubMed    
    
    
    
88. QAYYUM F, Lauridsen B, Frikke-Schmidt R, Nordestgaard B, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Atherosclerosis. 2017;263:e21.
    PubMed    
    
    
    
89. PAPADOPOULOS D, Grassos H, Sanidas E, Barbetseas J, et al
    Triglyceride blood levels and metalloproteinases activity in acute myocardial infarction patients.
    Atherosclerosis. 2017;263:e203.
    PubMed    
    
    
    
90. FEDOROVA N, Kashtalap V, Barbarash O
    Galectin-3 levels in patients with ST segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e199.
    PubMed    
    
    
    
91. PECHERINA T, Kashtalap V, Barbarash O, Zhuravleva E, et al
    The value of matrix metalloproteinases in coronary atherosclerosis progression in patients after ST-segment elevation myocardial infarction in one year.
    Atherosclerosis. 2017;263:e198.
    PubMed    
    
    
    
92. ZIVOTIC I, Zivkovic M, Djuric T, Stankovic A, et al
    Rs10757278 from 9p21 is associated with ST-elevated myocardial infarction in females in population of Serbia.
    Atherosclerosis. 2017;263:e188.
    PubMed    
    
    
    
93. FARES AL, Hussein El Bacha AA, Souza CS, Garcia De Carvalho JA, et al
    High prevalence of familial hypercholesterolemia in patients with coronary heart disease at a Brazilian quaternary healthcare center.
    Atherosclerosis. 2017;263:e181-e183.
    PubMed    
    
    
    
94. DJORDJEVIC A, Zivkovic M, Dekleva M, Markovic-Nikolic N, et al
    SNPS in the vicinity of LGALS-3 locus and different shape-types of heart remodeling after the first myocardial infarction: Preliminary results.
    Atherosclerosis. 2017;263:e180.
    PubMed    
    
    
    
95. NUSSBAUMEROVA B, Rosolova H, Mayer O Jr, Filipovsky J, et al
    Residual cardiovascular risk in patients with stable coronary heart disease over the last 16 years (Czech part of the EUROASPIRE I-IV surveys).
    Atherosclerosis. 2017;263:e177.
    PubMed    
    
    
    
96. KASHTALAP V, Barbarash O, Gorbunova E, Sedyh D, et al
    Psychophysiological personality characteristics of patients with recurrent myocardial infarction.
    Atherosclerosis. 2017;263:e174.
    PubMed    
    
    
    
97. IGNATEVA O, Berkovich O, Volkova E, Moroshkina N, et al
    S19W polymorphism of apo AV is an independent risk factor for myocardial infarction among young men.
    Atherosclerosis. 2017;263:e173-e174.
    PubMed    
    
    
    
98. DIAZ-PEROMINGO JA, Macia-Rodriguez C, Alende-Castro V, Paez-Guillan E, et al
    Comorbidity and sex differences among patients with ischemic heart disease currently smokers.
    Atherosclerosis. 2017;263:e172.
    PubMed    
    
    
    
99. KECHIDA M, Jomaa W, Hamda KB, Klii R, et al
    Myocardial infarction as a first symptom of activated protein C resistance associated to hyperhomocyteinemia.
    Atherosclerosis. 2017;263:e162.
    PubMed    
    
    
    
100. NIZOMOV A, Kenjaev M, Kenjaev S, Kenjaev S, et al
     The relationship between the parameters of longitudinal systolic function and left ventricular remodeling in patients with acute myocardial infarction.
     Atherosclerosis. 2017;263:e159.
     PubMed    
     
     
     
101. HONG TJ, Lee HW, Choi JH, Choi JC, et al
     Comparison of long term clinical outcomes between bare metal stent versus different types of drug eluting stents for treatment of acute myocardial infarction.
     Atherosclerosis. 2017;263:e155-e156.
     PubMed    
     
     
     
102. SHALAEVA A, Dadabaeva N
     Compliance initiatives in management of patients with coronary artery disease after acute myocardial infarction.
     Atherosclerosis. 2017;263:e152-e153.
     PubMed    
     
     
     
103. SHAH N, Meira L, Elliott R, Bordin D, et al
     DNA repair measuring DNA ligase activity in non ST-elevation myocardial infarction determines atherosclerotic plaque instability.
     Atherosclerosis. 2017;263:e143.
     PubMed    
     
     
     
104. SHAH N, Meira L, Forrer-Charlier C, Mahmoudi M, et al
     Up-regulation of base excision repair gene 8-oxoguanine glycosylase 1 expression in non ST-elevation myocardial infarction and correlation with atherosclerotic fibrous cap thickness.
     Atherosclerosis. 2017;263:e142-e143.
     PubMed    
     
     
     
105. ROMANOVA V
     Condition of adhesive endothelial function in coronary heart disease patients.
     Atherosclerosis. 2017;263:e141.
     PubMed    
     
     
     
106. DUMITRIU IE, Bulenkamp J, Chhetri I
     Homeostatic cytokines interleukin-7 (IL-7) and IL-15 drive the expansion and activation of CD4+CD28null t cells in patients with myocardial infarction.
     Atherosclerosis. 2017;263:e14-e15.
     PubMed    
     
     
     
107. NIZOMOV A, Kenjaev S, Kenjaev M, Mukhamedova M, et al
     Dynamics of indicators of longitudinal left ventricular systolic function in patients with acute myocardial infarction during stress echocardiography with dobutamine.
     Atherosclerosis. 2017;263:e122.
     PubMed    
     
     
     
108. MUSIKHINA N, Petelina T, Gapon L, Emeneva I, et al
     Peculiarity of vascular inflammatory response in patients with unstable angina.
     Atherosclerosis. 2017;263:e118.
     PubMed    
     
     
     
109. VERWEIJ S, Delewi R, Stiekema L, Versloot M, et al
     Prolonged inflammatory state after myocardial infarction.
     Atherosclerosis. 2017;263:e117-e118.
     PubMed    
     
     
     
110. KUMAR V
     Demonstrating the decline in coronary heart disease mortality in the Central Delhi, India between 2010 to 2015.
     Atherosclerosis. 2017;263:e110.
     PubMed    
     
     
     
111. DE GONZALO CALVO D, Sanchez Vega J, Vilades D, Nasarre L, et al
     Diagnostic value of circulating miRNAs: Association with the presence and extension of coronary atherosclerosis in patients with suspected ischemic heart disease.
     Atherosclerosis. 2017;263:e106.
     PubMed    
     
     
     July 2017
112. AGARWALA A, Pokharel Y, Saeed A, Sun W, et al
     The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
     Atherosclerosis. 2017;262:131-137.
     PubMed     Abstract available
     
     
     
113. HOLMLUND A, Lampa E, Lind L
     Oral health and cardiovascular disease risk in a cohort of periodontitis patients.
     Atherosclerosis. 2017;262:101-106.
     PubMed     Abstract available
     
     
     
114. CHUNG RWS, Leanderson P, Lundberg AK, Jonasson L, et al
     Lutein exerts anti-inflammatory effects in patients with coronary artery disease.
     Atherosclerosis. 2017;262:87-93.
     PubMed     Abstract available
     
     
     
115. TOUTOUZAS K, Benetos G, Koutagiar I, Barampoutis N, et al
     Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
     Atherosclerosis. 2017;262:25-30.
     PubMed     Abstract available
     
     
     
116. ZHANG Q, Wang A, Zhang S, Li N, et al
     Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
     Atherosclerosis. 2017;262:1-7.
     PubMed     Abstract available
     
     
     
117. CHO I, O Hartaigh B, Gransar H, Valenti V, et al
     Prognostic implications of coronary artery calcium in the absence of coronary artery luminal narrowing.
     Atherosclerosis. 2017;262:185-190.
     PubMed     Abstract available
     
     
     June 2017
118. VONGPROMEK R, Bos S, Ten Kate GR, Bujo H, et al
     Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
     Atherosclerosis. 2017 Jun 9. pii: S0021-9150(17)30268.
     PubMed     Abstract available
     
     
     
119. FAIROOZY RH, Cooper J, White J, Giambartolomei C, et al
     Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
     Atherosclerosis. 2017;261:60-68.
     PubMed     Abstract available
     
     
     
120. WANG A, Kwee LC, Grass E, Neely ML, et al
     Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
     Atherosclerosis. 2017;261:19-25.
     PubMed     Abstract available
     
     
     
121. NAKAJIMA S, Ito H, Mitsuhashi T, Kubo Y, et al
     Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography.
     Atherosclerosis. 2017;261:138-143.
     PubMed     Abstract available
     
     
     
122. TADA H, Kawashiri MA, Sakata K, Yoneda T, et al
     Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.
     Atherosclerosis. 2017;261:111-116.
     PubMed     Abstract available
     
     
     May 2017
123. SHARIFI M, Higginson E, Bos S, Gallivan A, et al
     Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
     Atherosclerosis. 2017 May 13. pii: S0021-9150(17)30218.
     PubMed     Abstract available
     
     
     
124. GLEISSNER CA, Erbel C, Linden F, Domschke G, et al
     Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
     Atherosclerosis. 2017;260:121-129.
     PubMed     Abstract available
     
     
     
125. VERDOIA M, Nardin M, Rolla R, Marino P, et al
     Immature platelet fraction and the extent of coronary artery disease: A single centre study.
     Atherosclerosis. 2017;260:110-115.
     PubMed     Abstract available
     
     
     
126. PANH L, Ruidavets JB, Rousseau H, Petermann A, et al
     Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients.
     Atherosclerosis. 2017;260:81-86.
     PubMed     Abstract available
     
     
     
127. BASKARAN L, O Hartaigh B, Schulman-Marcus J, Gransar H, et al
     Dense calcium and lesion-specific ischemia: A comparison of CCTA with fractional flow reserve.
     Atherosclerosis. 2017;260:163-168.
     PubMed     Abstract available
     
     
     April 2017
128. MANGILI LC, Miname MH, Silva PRS, Bittencourt MS, et al
     Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
     Atherosclerosis. 2017 Apr 30. pii: S0021-9150(17)30189.
     PubMed     Abstract available
     
     
     
129. KITAHARA H, Waseda K, Sakamoto K, Yamada R, et al
     Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
     Atherosclerosis. 2017;259:68-74.
     PubMed     Abstract available
     
     
     March 2017
130. LI S, Wu NQ, Zhu CG, Zhang Y, et al
     Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
     Atherosclerosis. 2017;260:67-74.
     PubMed     Abstract available
     
     
     
131. KITAGAWA K, Amano T, Uetani T, Ishii H, et al
     Association between plaque characteristics and the amount of debris captured by a filter-type distal protection device in patients with acute coronary syndrome.
     Atherosclerosis. 2017;258:72-78.
     PubMed     Abstract available
     
     
     
132. KWON CH, Kang JG, Lee HJ, Kim NH, et al
     Absence of association between gallstone and coronary artery calcification.
     Atherosclerosis. 2017;258:51-55.
     PubMed     Abstract available
     
     
     
133. RIZVI A, Hartaigh BO, Danad I, Han D, et al
     Diffuse coronary artery disease among other atherosclerotic plaque characteristics by coronary computed tomography angiography for predicting coronary vessel-specific ischemia by fractional flow reserve.
     Atherosclerosis. 2017;258:145-151.
     PubMed     Abstract available
     
     
     
134. ABD-ELMONIEM KZ, Ramos N, Yazdani SK, Ghanem AM, et al
     Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.
     Atherosclerosis. 2017;258:20-25.
     PubMed     Abstract available
     
     
     
135. SHAHID SU, Shabana, Cooper JA, Beaney KE, et al
     Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants.
     Atherosclerosis. 2017;258:1-7.
     PubMed     Abstract available
     
     
     
136. CAMPOS AM, Moura FA, Santos SN, Freitas WM, et al
     Sarcopenia, but not excess weight or increased caloric intake, is associated with coronary subclinical atherosclerosis in the very elderly.
     Atherosclerosis. 2017;258:138-144.
     PubMed     Abstract available
     
     
     
137. MADSEN DM, Diederichsen ACP, Hosbond SE, Gerke O, et al
     Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
     Atherosclerosis. 2017;258:131-137.
     PubMed     Abstract available
     
     
     February 2017
138. CHRISTIANSEN MK, Nyegaard M, Pedersen LN, Larsen SB, et al
     A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering.
     Atherosclerosis. 2017;257:172-178.
     PubMed     Abstract available
     
     
     
139. OSAWA K, Nakanishi R, Budoff MJ
     Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease?
     Atherosclerosis. 2017;257:279-287.
     PubMed     Abstract available
     
     
     
140. LIN JF, Wu S, Juang JJ, Chiang FT, et al
     IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
     Atherosclerosis. 2017;257:71-77.
     PubMed     Abstract available
     
     
     
141. DE VRIES MA, Trompet S, Mooijaart SP, Smit RA, et al
     Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.
     Atherosclerosis. 2017;257:16-21.
     PubMed     Abstract available
     
     
     
142. KIM J, Budoff MJ, Nasir K, Wong ND, et al
     Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).
     Atherosclerosis. 2017;257:1-8.
     PubMed     Abstract available
     
     
     
143. LEE EM, Choi MH, Seo HS, Kim HK, et al
     Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
     Atherosclerosis. 2017;257:195-200.
     PubMed     Abstract available
     
     
     
144. CHEEZUM MK, Kim A, Bittencourt MS, Kassop D, et al
     Association of tobacco use and cessation with coronary atherosclerosis.
     Atherosclerosis. 2017;257:201-207.
     PubMed     Abstract available
     
     
     January 2017
145. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
     An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
     Atherosclerosis. 2017;258:40-50.
     PubMed     Abstract available
     
     
     
146. WIDHALM K, Benke IM, Fritz M, Geiger H, et al
     Homozygous familial hypercholesterolemia: Summarized case reports.
     Atherosclerosis. 2017;257:86-89.
     PubMed     Abstract available
     
     
     
147. BRUCKERT E, Kalmykova O, Bittar R, Carreau V, et al
     Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
     Atherosclerosis. 2017;257:130-137.
     PubMed     Abstract available
     
     
     
148. BOS S, Duvekot MH, Ten Kate GR, Verhoeven AJ, et al
     Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
     Atherosclerosis. 2017;256:62-66.
     PubMed     Abstract available
     
     
     
149. NONIN S, Iwata S, Sugioka K, Fujita S, et al
     Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
     Atherosclerosis. 2017;256:29-34.
     PubMed     Abstract available
     
     
     December 2016
150. LEE DH, Chun EJ, Hur JH, Min SH, et al
     Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
     Atherosclerosis. 2016;257:47-54.
     PubMed     Abstract available
     
     
     November 2016
151. SCICALI R, Giral P, Gallo A, Di Pino A, et al
     HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
     Atherosclerosis. 2016;255:102-108.
     PubMed     Abstract available
     
     
     
152. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
     Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
     Atherosclerosis. 2016;255:73-79.
     PubMed     Abstract available
     
     
     October 2016
153. OGURA M, Makino H, Kamiya C, Yoshimatsu J, et al
     Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion.
     Atherosclerosis. 2016;254:179-183.
     PubMed     Abstract available
     
     
     September 2016
154. MANGILI LC, Mangili OC, Bittencourt MS, Miname MH, et al
     Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.
     Atherosclerosis. 2016;254:73-77.
     PubMed     Abstract available
     
     
     August 2016
155. ALONSO R, Mata P, Muniz O, Fuentes-Jimenez F, et al
     PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
     Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31306.
     PubMed     Abstract available
     
     
     
156. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
     Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
     Atherosclerosis. 2016;253:1-6.
     PubMed     Abstract available
     
     
     July 2016
157. WATTS GF, Pang J, Chan DC, Brunt JN, et al
     Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
     Atherosclerosis. 2016;252:82-87.
     PubMed     Abstract available
     
     
     May 2016
158. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
     Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
     Atherosclerosis. 2016;250:114-121.
     PubMed     Abstract available
     
     
     
159. MENEGAUT L, Masson D, Abello N, Denimal D, et al
     Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
     Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: